Podcasts about medical affairs

About this episode:  Sickle cell disease affects an estimated 100,000 people in the United States. Recent advancements in gene therapies and medicines like hydroxyurea are diminishing extreme pain, reducing strokes, and extending survival times for those afflicted by the disease. In this episode: leading sickle cell disease expert Dr. Mark Gladwin explains how revolutionary new treatments work and discusses the challenges to access to life-saving care. Guest: Dr. Mark Gladwin is a physician-scientist and the Dean of the University of Maryland School of Medicine and Vice President for Medical Affairs at the University of Maryland, Baltimore. His research focuses include sickle cell disease and hypertension. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle—CNBC Gene Therapy: What You Need to Know—Sickle Cell Disease Association of American No More Pain: Breakthrough Sickle Cell Treatment from Johns Hopkins Offers Curative Potential—Johns Hopkins School of Medicine Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Medical misinformation, life sciences burnout, and AI-powered content creation collide in this episode with Dr. Ome Ogbru, founder & CEO of AINGENS and creator of MACg (Medical Affairs Content Generator). Learn how AI in biotech is tackling the complexities of medical affairs—from literature review and content automation to compliance and regulatory writing.⚡️ WHAT YOU'LL LEARN:- Why medical affairs and regulatory teams can't rely on ChatGPT alone.- How MACg integrates real‑time PubMed search, citation generation, and secured collaboration to streamline scientific writing - Why MACg users report up to 50 % faster writing and 50–70 % faster medical-legal review.- Why AI platforms like MACg must be purpose-built for life sciences (GDPR & SOC 2 compliant).- What is “human-in-the-loop” AI workflow—and how it balances automation and review to maintain accuracy and trust.- Real-world use cases: scientific summaries, medical info letters and more.

From chatbots and content generation to insights mining and decision support, GenAI is moving from buzzword to backbone. In this "Elevate" episode, our hosts Jennifer Riggins & Steve Casey speak to a panel of experts on the frontlines of GenAI implementation to share their hard-won insights.

In this episode of Transforming Medical Communications, Wesley Portegies is joined by MedComms strategist, J.R. Meloro, to discuss why mastering smarter metrics is no longer optional for Medical Affairs leaders; it's a necessity. Learn how to move beyond outdated metrics and implement smarter, more meaningful measurement strategies. Metrics should be your roadmap to better decisions, but only if you know how to use them effectively. The future of Medical Affairs depends on how well you track and act on data; those who don't evolve will fall behind.

It’s no secret that our lifespans – especially women’s – have drastically increased over the last several decades, but what about healthspans? How can we make those additional years healthier and happier? Speaking live at City Winery in NYC, join Katie and Dr. Krys Araujo-Torres, Head of U.S. Medical Affairs for Nature's Bounty, as they dig into the simple, effective steps we can take to live our best lives. #adSee omnystudio.com/listener for privacy information.

Welcome to Health-e Law, Sheppard Mullin's podcast exploring the fascinating health tech topics and trends of the day. In this episode, Sara Shanti welcomes Bill Kish and Dr. Brad Pruitt of Kenosha AI to explore how artificial intelligence can enhance efficiency and compliance in healthcare research. What is Kenosha AI, and what is its potential role in transforming healthcare and research operations? Who are the end users of Kenosha AI's products, and how are these products positioned to deliver immediate, tangible impacts for their missions? Looking ahead, how might this momentum build, and what direction could clinical research take with the advancements enabled by AI? What are the risks and concerns associated with hallucinations, synthetic data, and the trustworthiness of AI deliverables? Where can healthcare stakeholders feel comfortable jumping in on AI, and where does it make sense to wait for further development? What tasks should clinicians and researchers prioritize when exploring the potential applications of AI?   About Bill Kish Bill Kish is the CEO and Co-Founder of Kenosha AI, bringing over 30 years of dynamic experience as a technologist, entrepreneur, and leader across five successful startups. His expertise has led burgeoning companies to flourish into multi-billion-dollar enterprises, solidifying his position as an industry innovator. A graduate with honors in Computer Engineering from Carnegie Mellon University, Bill's career has been defined by groundbreaking advancements in AI and machine learning applications. He co-founded Ruckus Wireless, serving as CTO and Board Director, where his contributions shaped the company into a $400M/year business and a leader in the wireless technology industry, culminating in a $1.5 billion acquisition by Brocade. At Cogniac Corporation, Bill enabled industries to leverage AI-powered visual inspection, serving as the CEO and CTO to drive operational innovation. He also founded Jiggy AI, a boutique AI consulting firm specializing in large language model applications. Additionally, as the organizer of the Silicon Valley Machine Learning Meetup, Bill has fostered a thriving global community of over 10,000 members passionate about machine learning. About Dr. Brad Pruitt Dr. Brad Pruitt is the President and Co-Founder of Kenosha AI. With over 25 years of experience in clinical research and healthcare, including 13 years in the Contract Research Organization (CRO) industry, he specializes in revolutionizing clinical trials through advanced AI-powered tools like copilots and GPTs.  Dr. Pruitt is a seasoned executive and entrepreneur with a proven track record of leading ventures to success. He has held executive roles at top-tier CROs, served as the Founding CEO of an acquired startup, and contributed to three successful acquisitions in the past eight years. His prior leadership roles include Chief Medical Officer at Alethium Health Systems, where he developed go-to-market strategies for clinical trial innovation, and Senior Vice President of Medical Affairs at Safe Health, where he drove business expansion into connected diagnostics.  In addition to his role with Kenosha AI, Dr. Pruitt is a Principal at Prucor and serves as a mentor and advisor for healthcare and clinical trial technology companies participating in the EvoNexus incubator program. Dr. Pruitt earned his MD from Michigan State University College of Human Medicine and his MBA from UC San Diego's Rady School of Management. His academic foundation, combined with his professional achievements, positions him as a visionary leader at the intersection of technology, healthcare, and clinical research. About Sara Shanti A partner in the Corporate Practice Group in Sheppard Mullin's Chicago office and co-lead of its Digital Health Team, Sara Shanti's practice sits at the forefront of healthcare technology by providing practical counsel on novel innovation and complex data privacy matters. Using her medical research background and HHS experience, Sara advises providers, payors, start-ups, technology companies, and their investors and stakeholders on digital healthcare and regulatory compliance matters, including artificial intelligence (AI), augmented and virtual reality (AR/VR), gamification, implantable and wearable devices, and telehealth. At the cutting edge of advising on "data as an asset" programming, Sara's practice supports investment in innovation and access to care initiatives, including mergers and acquisitions involving crucial, high-stakes and sensitive data, medical and wellness devices, and web-based applications and care.   Contact Information Bill Kish Dr. Brad Pruitt Sara Shanti   Additional Resources Kenosha AI - Kenosha AI is currently offering a free trial of its RegChatTM, which is an AI-powered Clinical Regulatory Guidance Assistant that provides a simple chat interface for answering questions about global regulatory guidance using AI and official regulatory guidance documents with referenced summarizations and multi-agency comparisons. Find it at RegChat.com.  Thank you for listening! Don't forget to SUBSCRIBE to the show to receive new episodes delivered straight to your podcast player every month. If you enjoyed this episode, please help us get the word out about this podcast. Rate and Review this show on Apple Podcasts, Amazon Music, or Spotify. It helps other listeners find this show. This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matter, be sure to consult with an attorney regarding your specific needs.

Being a pharmacist is exciting–as long as you're willing to try new things. These are wise words from my returning guest on today's podcast, who has been paving the way for integrative pharmacy. Dr. Swathi Varanasi is an award-winning pharmacist passionate about the intersection of personalized medicine, patient outcomes, and innovation. With experience spanning patient care, biotech, research, academia, and consumer product goods, Dr. Swathi has paved the way for healthcare professionals to pursue non-traditional career paths through creating postdoctoral training programs, industry internships, and online educational programs. She co-founded and serves as Chief Scientific Officer of the Life Sciences Division at Element Apothec, and serves as a Principal Investigator at contract research organization, Citruslabs. Dr. Swathi received her Doctor of Pharmacy (PharmD) at the Medical University of South Carolina and Bachelor of Arts (BA) at Carleton College. She was the first-ever pharmacist in the United States with formal residency training to specialize in integrative medicine and preventative health. She also completed a postdoctoral fellowship in Medical Affairs in biotech and has training in nutrition from Cornell University. Dr. Swathi has served as faculty and guest lectures at colleges and universities across the country. She is an advisor and consultant for a number of for-profit and nonprofit organizations aiming to make the world a healthier place for us to live–and thrive. She has been published in peer-reviewed academic journals and featured in Yahoo, mindbodygreen, Well+Good, Entrepreneur, Forbes Health, and more. In 2023, Dr. Swathi was voted one of the 50 Most Influential Leaders in Pharmacy. Connect with Dr. Swathi via: Email: swathimvaranasi@gmail.com  FB: Doctor Swathi  IG: @drswathivaranasi Linked In:Dr. Swathi Varanasi  Check out our earlier episode here: https://www.marinabuksov.com/s03e03-paving-the-unconventional-path-with-integrative-pharmacist-dr-swathi-varanasi/ 

In this candid and wide-ranging conversation, we sit down with Dr. Brian Schmutzler — anesthesiologist, social media educator, and Executive Vice President of Medical Affairs at CCI Anesthesia — to unpack what it really means to lead in modern anesthesia. From the realities of staffing rural hospitals without anesthesiologists to fighting burnout, navigating private equity, and fiercely defending provider scope and safety, Brian shares hard-earned insights from both clinical and corporate perspectives.We also dive into the power of humor and education on social media, his 108K-strong Instagram following, and how his content brings awareness, advocacy, and levity to patients and practitioners alike.If you're a CRNA, MD, administrator, or just someone trying to understand where anesthesia is headed — and how to lead within it — this is an episode you can't miss.Keywords:Leadership, Anesthesia, Social Media, Burnout, Independent PracticeSend us a textFollow us at:InstagramFacebookTwitter/X

In this third episode of the OncoExTra® podcast series, host Ruchika Talwar, MD, talks with Christy Russell, MD, Vice President of Medical Affairs at Exact Sciences, about what oncologists can expect when they receive their OncoExTra comprehensive genomic profiling test results, and how they can utilize the report and tap into Exact Sciences' skilled support team to develop a plan of action for their patients.

Send us a textDr. Marc Salzberg, MD is President, Chief Executive Officer & Chief Medical Officer of Airway Therapeutics ( https://www.airwaytherapeutics.com/ ), a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases.Dr. Salzberg has more than 25 years of academic and pharmaceutical experience in the management of drug development and clinical research, including medical management of anti-viral drugs clinical development and market introduction including saquinavir and ganciclovir. He spent several years at Roche's headquarters in Basel, Switzerland as well as its affiliate in Toronto, Canada. As Head of Clinical Cancer Research at the Basel University, he co-founded and managed a clinical research network in Switzerland (CCRC).During his career, Dr. Salzberg has successfully managed the growth and acquisition of two contract research organizations benefitting shareholders. He was a founder and President of Pharma Brains, a European boutique CRO, which has been acquired by Medpace, a US based global CRO, after 10 years of successful growth under his leadership. He then served as Vice President of Medical Affairs at Medpace.Dr. Salzberg earned his Medical Doctorate degree from the University of Basel, Switzerland. His medical training and practice include pediatrics/ neonatology and oncology.#MarcSalzberg #AirwayTherapeutics #HumanSurfactantProteinD #Collectin #PathogenRecognition #RespiratoryDiseases  #InflammatoryResponse #BronchopulmonaryDysplasia #ZelpultideAlfa #Covid #Asthma #COPD #Influenza #RSV #ARDS #AcuteRespiratoryDistressSyndrome #ChronicObstructivePulmonaryDisease #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

What is the environmental impact of respiratory illness? Find out in this episode of the EMJ GOLD podcast, where Shish Patel, Medical Director, Chiesi UK, joins Isabel to discuss the rising burden of COPD and the impact of respiratory care on the planet.  Together, the two explore the diagnostic gap in COPD, improving the experience of people living with the disease, balancing health innovation with climate concerns and much more.   A little more on EMJ GOLD's guest…  Shish Patel trained as a pharmacist and has worked in the pharmaceutical industry for over 30 years. Currently, he serves as Medical Director at Chiesi UK and Ireland, and he has held senior positions within medical and scientific functions at both affiliate and global level throughout his career. In addition to his significant time at Chiesi, Shish has held positions at GSK and Sanofi. Shish also holds key industry board positions including at the Prescription Medicines Code of Practice Authority and the ABPI.   

In this solo episode of Transforming Medical Communications, host Wesley Portegies draws from the 2025 State of MedComms survey to explore what pharma teams truly want from their agency partners. And the answer isn't more slide decks. It's strategy. Wesley breaks down the five capabilities that Medical Affairs leaders expect from modern agencies, ranging from scientific depth to digital fluency, and explains why empathy, insight, and operational awareness are just as important as technical skill. He also shares a practical example that reveals the difference between a transactional vendor and a true thought partner, and offers clear steps to activate more strategic collaboration.

This episode recorded live at the Becker's 3rd Annual Spring Payer Issues Roundtable features Illan Shapiro Strygler, Chief Health Correspondent and Medical Affairs Officer and Senior Vice President, AltaMed Health Services. Dr. Shapiro shares how AltaMed leverages data, cultural understanding, and community connection to improve care quality, reduce costs, and advance health equity.

In this compelling episode of LOVE TALK, hosts Coach Kerri Brinkoeter and Marlene McMichael welcome Dr. Ingrid Skop, a seasoned OB/GYN and Vice President of Medical Affairs at the Charlotte Lozier Institute, to share her insights as a nationally recognized voice in the pro-life movement. Dr. Skop discusses her decades of medical experience, particularly the dangers of the abortion pill, the misperceptions about pro-life legislation, and the misinformation propagated by organizations like Planned Parenthood. She also highlights her peer-reviewed research, which has drawn criticism and censorship attempts from pro-abortion advocates. Through her work, including contributions to VoyageOfLife.com, Dr. Skop emphasizes the importance of truth, scientific integrity, and the value of every human life, offering both professional and personal insight into one of the nation’s most emotionally charged issues.

This episode recorded live at the Becker's 3rd Annual Spring Payer Issues Roundtable features Illan Shapiro Strygler, Chief Health Correspondent and Medical Affairs Officer and Senior Vice President, AltaMed Health Services. Dr. Shapiro shares how AltaMed leverages data, cultural understanding, and community connection to improve care quality, reduce costs, and advance health equity.

In this special edition of the EMJ GOLD podcast, Isabel and Jade dive into the latest insights from recent contributors and EMJ's own data to uncover what healthcare professionals really want from medical affairs. They explore the growing challenges of engaging HCPs, question whether there's a gap between what HCPs say they want and what actually captures their attention and look ahead to what the future may hold. Tune in for expert insights from guests including Dr Donatello Crocetta, Bora Erdemli, Cécile Janssenswillen, Dr Natalia Barkalina and Dheepa Chari.

During this episode you'll learn about: This week's guest: Dr. Mario Roxas, ND, Director of Scientific and Medical Affairs at Thorne [0:57] Travel's effects on the body, from jet lag to immune challenges [2:10] Roxas' top 3 supplements for travel [3:51] Common health challenges from travel [6:21] How to prepare for digestive upset [10:08] Tips for combating jet lag and staying rested while traveling [12:26] Questions from the community How do you choose which foods to try and which to avoid while traveling? [17:19] What causes traveler's constipation? [20:09] Can I pass through airport security and TSA checkpoints with powder supplements? [21:06] Resources to topics mentioned in this episode: What Inspires Us to Innovate, with Mario Roxas, Director of Research and Development Tips for Healthy Traveling This Summer Mayo Clinic: The Globetrotter's Guide to Dealing with Gut Health Issues While Traveling These Are the Ideal Supplements to Pack While Traveling Mayo Clinic: A Traveler's Guide to Immunity Health Keep Your Gut Healthy While Traveling Mayo Clinic: Don't Let Jet Lag Derail Your Vacation Can You Bring Vitamins on a Plane? How To Travel with Supplements How Does Thorne Support Traveling Athletes? Products related to this episode: Daily Greens Plus, Sacro-B™, Daily Electrolytes, Advanced Digestive Enzymes, Magnesium Bisglycinate, Melaton-3™ Subscribe to More Content Subscribe to the show wherever you listen to podcasts so you never miss an episode. You can also learn more about the topics in the episode by checking out the latest news, videos, and stories on Thorne's Take 5 Daily blog.

Getting an autoimmune disease diagnosis can feel like solving a medical mystery. In this powerful interview, we explore why so many people struggle for years before finally receiving answers. From vague symptoms and misdiagnoses to medical gaslighting and gaps in conventional testing, we break down the challenges of getting properly diagnosed—and what you can do to advocate for yourself along the way. If you've ever felt dismissed or overlooked by the healthcare system, this episode is for you. I talk with a medical expert on the science of autoimmune disease diagnosis about why doctors can have such a hard time with autoimmune disease diagnoses.  Tyler O'Malley serves as Associate VP of Clinical Affairs & Market Access at Exagen Inc., a leader in autoimmune testing solutions. In his role, he oversees clinical trials, bioinformatics, and medical policy development for Exagen's current diagnostic portfolio and pipeline of proprietary solutions. With more than a decade of experience, O'Malley has contributed to more than a dozen clinical trials, focusing on clinical validity and utility evidence for autoimmune diagnostics. His expertise is widely recognized, with numerous publications in esteemed peer-reviewed journals. Notably, he is the first author of one of the largest clinical utility studies in lupus diagnostics. O'Malley graduated from Georgia Gwinnett College with a Bachelor of Science in biology, concentrating in biochemistry. His eleven-year career in Research and Development and Medical Affairs encompassed medical science education, assay development, and clinical research coordination. http://exagen.com Website for this episode: http://autoimmunerehab.com Youtube channel: https://youtube.com/c/annalaurabrownhealthcoach  

In this episode, Kristen is joined by Dr. Marschall Runge, Executive VP for Medical Affairs at the University of Michigan and author, to explore how true healthcare disruption begins with integrating emotional and mental health into patient care. They discuss the promise and limitations of AI in medicine and why supporting the mental well-being of healthcare providers is more essential than ever.     https://drmarschallrunge.com/ https://www.codedtokill.com/     When you purchase these books through these Amazon links, you're helping support the podcast at no extra cost to you. 1. The Great Healthcare Disruption (Audiobook): Big Tech, Bold Policy, and the Future of American Medicine: https://amzn.to/3FHmjsi 2. The Great Healthcare Disruption: Big Tech, Bold Policy, and the Future of American Medicine Hardcover: https://amzn.to/45gZyFV Recommendations: 1. Super Agers: An Evidence-Based Approach to Longevity: https://amzn.to/4mYbwe8 2. Make Magic: The Book of Inspiration You Didn't Know You Needed: https://amzn.to/4l17CiM     Subscribe and get a free 5-day journal at www.kristendboice.com to begin closing the chapter on what doesn't serve you and open the door to the real you. This information is being provided to you for educational and informational purposes only. It is being provided to you to educate you about ideas on stress management and as a self-help tool for your own use. It is not psychotherapy/counseling in any form. This information is to be used at your own risk based on your own judgment.  For my full Disclaimer please go to www.kristendboice.com. For counseling services near Indianapolis, IN, visit www.pathwaystohealingcounseling.com. Pathways to Healing Counseling's vision is to provide warm, caring, compassionate and life-changing counseling services and educational programs to individuals, couples and families in order to create learning, healing and growth.

In this episode, Dr. Terrance Govender, VP of Medical Affairs at ClinIntell, discusses solving the physician engagement puzzle & why it matters for hospital finance.

In this episode of Medical Affairs unscripted, Peg Crowley-Nowick, PhD, MBA, Senior Advisor, Medical Affairs Consulting at Lumanity, and Cathy Symonds, PhD, Program Lead and Head of New Product Planning at Arbor Biotechnologies, engage in an insightful discussion about the evolving role of new product planning and its intersection with Medical Affairs. Peg and Cathy explore the strategic importance of new product planning in the lifecycle of medical products, emphasizing how early commercial strategy is essential for successful development and market entry. They discuss various frameworks and best practices, including the creation of a Target Product Profile (TPP), which helps align the team on what success looks like and guides the development process from early stages through to commercialization. The conversation delves into the critical partnerships between new product planning and other functions such as Medical Affairs, clinical development, and market access. They highlight how these collaborations are essential for gathering comprehensive insights from healthcare professionals, patients, and the broader market landscape. They share their experiences and perspectives on the importance of strategic narratives that communicate the value of new products effectively to both internal teams and external stakeholders, including investors. Throughout the discussion, they underscore the necessity of continuous planning and adaptation to ensure that products not only meet regulatory requirements but also achieve commercial success and ultimately improve patient outcomes.

Today's guest is Dr. Ankur Sharma, Head of Medical Affairs for Medical Devices and Digital Radiology at Bayer. Dr. Sharma joins Emerj Editorial Director Matthew DeMello to explore the complex intersection of AI, medical devices, and data governance in healthcare. Dr. Sharma outlines the key challenges that healthcare institutions face in adopting AI tools, including data privacy, system interoperability, and regulatory uncertainty. He also clarifies the distinction between regulated predictive models and unregulated generative tools, as well as how each fits into current clinical workflows. The conversation explores the evolving roles of the FDA and EU AI Act, the potential for AI to bridge clinical research and patient care, and the need for new reimbursement models to support digital innovation. This episode is sponsored by Medable. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the ‘AI in Business' podcast!

MedComms is overdue for a reboot. Static PDFs. Oversized decks. Siloed teams. No feedback loops. These outdated practices are slowing teams down and wasting valuable resources. In this episode of Transforming Medical Communications, Wesley Portegies shares bold insights from the State of Medical Communications 2025 survey and breaks down three urgent trends that pharma leaders can't afford to ignore. From dismantling silos to killing the static PDF once and for all, this episode offers a practical roadmap to modernize how Medical Affairs teams create, deliver, and measure content.

Dr. William Soliman is the founder and CEO of the Accreditation Council for Medical Affairs (ACMA). The ACMA is America's leader in life sciences accreditation, certification & training.  Soliman is a former pharmaceutical executive who worked in leadership roles at Merck, Abbvie, Gilead and more. He is considered a pharma industry futurist and has been featured on NewsNation, Fox News, Newsmax, Forbes, Al Jazeera, Yahoo Business TV, ABC News Radio & more. The ACMA established the first ever certification standards in the United States and stands as a benchmark of excellence for prior authorization professionals, reimbursement professionals, pharmaceutical sales professionals, medical science liaisons and medical affairs professionals.  Dr. Soliman received his PhD from Columbia University & his BA from New York University.

Medical Affairs is evolving, but are we evolving with it? In this episode of Transforming Medical Communications, host Wesley Portegies sits down with Kimberly Eskridge-Rose, a pioneering voice in digital transformation for Medical Affairs. Together, they discuss what it takes to move from cautious experimentation to a scalable and cross-functional social media strategy.

Marschall S. Runge, M.D., Ph.D., is the executive vice president for Medical Affairs at the University of Michigan, dean of the Medical School, and CEO of Michigan Medicine. He earned his doctorate in molecular biology at Vanderbilt University and his medical degree from Johns Hopkins School of Medicine, where he also completed a residency in internal medicine. He is the author of more than 250 publications and holds five patents for novel approaches to healthcare.  Today we talk about his new novel, “Coded to Kill: A Techno Medical Thriller.”  It is a supercharged fictional story about  how advancing technology in medicine is exploited with by a power hungry cabal and the offbeat cybersecurity team out to stop them.  A tough book to put down!

The EMJ GOLD podcast is back for a new season! In the first episode of season 10, the team are joined by Dheepa Chari, Vice President and Head of Global Scientific Communications, GSK, to discuss the past, present and future of scientific communications. Together, Dheepa and Isabel explore her journey from biostatistics to biopharma leadership — and the lessons learned along the way. They discuss what great science communication looks like, where it's heading next and why storytelling still matters in a digital-first world. Plus, expect practical insights on cross-functional collaboration and the growing role of AI. A little more on EMJ GOLD's guest… Dheepa Chari is the Vice President and Head of Global Scientific Communications at GSK. Here, she leads strategy and execution across Oncology, Vaccines, Specialty Care and General Medicine, driving innovation in how scientific narratives are delivered across channels. Before joining GSK in 2024, Dheepa held senior posts at Pfizer, Amgen and Novartis in both clinical and communications roles. Outside of work, Dheepa brings stories to life in a different way - as a singer-songwriter who regularly performs in New York City.

Joe Pardavila welcomes Dr. Marschall Runge, Dean of the University of Michigan Medical School and author of The Great Healthcare Disruption: Big Tech, Bold Policy, and the Future of American Medicine. Dr. Runge shares his bold vision for transforming the U.S. healthcare system, tackling pressing issues like physician burnout, AI-driven innovations, and the challenges of accessibility and affordability.From the potential of AI to streamline administrative tasks and improve patient care to the controversial role of government in healthcare, Dr. Runge doesn't shy away from hard truths. He discusses the obesity epidemic, the promise (and pitfalls) of drugs like Ozempic, and why a blended healthcare system—combining baseline government-provided care with optional private upgrades—could be the key to a healthier America.Whether you're frustrated with long wait times, high costs, or the complexities of modern medicine, this conversation offers fresh perspectives and provocative solutions. Tune in to hear why Dr. Runge believes disruption is exactly what healthcare needs—and how big tech and bold policy could reshape the future of American medicine.Dr. MARSCHALL RUNGE serves as Executive Vice President for Medical Affairs at the University of Michigan, dean of the Medical School, and CEO of Michigan Medicine. With advanced degrees from Vanderbilt and Johns Hopkins, and specialized training at Harvard's Massachusetts General Hospital, he has spent his career driving healthcare innovation and transforming medical education. His insights draw from decades of experience as both a practicing cardiologist and healthcare executive.

In the latest episode of Medical Affairs unscripted, Peg Crowley-Nowick, PhD and Senior Advisor, Medical Affairs Consulting at Lumanity, engages in a compelling conversation with Eva Gallagher, PhD, CNMAP, VP, Head of Medical Affairs at Agios Pharmaceuticals. They explore the strategic role of Medical Affairs in the rare disease space, discussing best practices for building effective teams, engaging diverse stakeholders, and leveraging digital tools for education. Eva's journey and success in the field offer a blueprint for how Medical Affairs can drive impactful change and enhance patient outcomes.   The discussion delves into the significance of starting Medical Affairs efforts early—sometimes as much as five to seven years before a product launch. Eva explains the critical need for educating healthcare practitioners about rare diseases, especially when those conditions are often not well-known. The episode also highlights the role of medical strategy, publication planning, and patient advocacy in creating a comprehensive approach to rare disease management. With practical examples and real-world insights, this episode provides a detailed roadmap for navigating the complexities of launching therapies in rare disease markets.

In this eye-opening conversation, we sit down with Dr. Ingrid Skop — a board-certified OB/GYN and Vice President of Medical Affairs at the Charlotte Lozier Institute — to unpack the critical issues surrounding women's health care. Dr. Skop shares her firsthand medical insight on the realities of abortion procedures, the risks of substandard care, and what women really need when facing unplanned pregnancies.We explore alternatives to abortion clinics, the importance of parental involvement laws, and the decline of essential services like cancer screenings and contraception. With compassion and clarity, Dr. Skop sheds light on what true, comprehensive care looks like — and how we can better support women both physically and emotionally.This is a conversation about facts, not politics. About healing, not headlines. And most of all, about the value of every woman and every life.https://lozierinstitute.org/team-member/ingrid-skop-m-d-facog/Recent News Summary:Leading up to a major budget vote in Congress, the U.S. House Rules Committee held an intense 21-hour hearing packed with high-profile Democratic leaders — including Minority Leader Hakeem Jeffries, House Whip Katherine Clark, and former Speaker Nancy Pelosi — pushing for amendments that included increased welfare spending without work requirements and continued funding for Planned Parenthood.One of the central points of contention was the claim that proposed budget cuts represented the “largest cut to health care in American history.” Critics argue that equating abortion with healthcare is misleading and point to serious concerns about Planned Parenthood's practices.Reports — including a disturbing exposé from The New York Times — have shed light on troubling conditions in some Planned Parenthood facilities, including botched procedures, leaking sewage, and poor medical oversight. These revelations come amid ongoing scrutiny of the organization's influence and funding, with statistics showing:    Nearly 400,000 abortions annually performed by Planned Parenthood — about 40% of all abortions in the U.S.    A 97% abortion rate for pregnant women who visit their clinics.    A decline in other services: cancer screenings, pap smears, and contraception services have all dropped sharply.    $2 million per day in taxpayer funding still flows to the organization, despite these declines.    Meanwhile, over 5 women have reportedly died from complications related to abortions performed there.Critics also highlight that there are over 15 times more community health centers nationwide that provide broader, life-affirming care without performing abortions — offering a more comprehensive and safer option for women in need.House Speaker Mike Johnson vowed to push the bill through by July 4th, saying the time has come to redirect federal resources toward truly compassionate and high-quality women's healthcare.Become a supporter of this podcast: https://www.spreaker.com/podcast/i-am-refocused-radio--2671113/support.

In this episode, you'll hear a conversation with three women's health experts about how early diagnostic testing is transforming care for heart disease, STIs, and preeclampsia. Discover how proactive screening empowers women, supports personalized care, and helps shift healthcare from reaction to prevention.   About Our Speakers:  Dr. Lindy Crimmins, Global Medical Affairs Manager. Lindy's clinical experience spans from emergency medicine to critical and primary care. Currently, she is responsible for providing medical support for the QuidelOrtho acute care menu throughout the product lifecycle. Lindy is passionate about education, testing guideline updates and assay utilization to drive improved patient-centered outcomes. Dr. Rea Castro, Director of Medical Affairs. Rea is a seasoned medical professional with extensive experience in pharmaceutical clinical development, biotechnology and diagnostic product development across multiple therapeutic areas, including immunology, oncology and women's health. She is currently a cross-functional leader in medical affairs and is committed to advancing healthcare outcomes through innovative research, quality healthcare delivery and rigorous safety standards. Vonda McAllister, Director of Global Product Management. Vonda's diagnostic experience spans from R&D and program management to marketing. Now a member of the Point of Care business unit, she previously managed the Triage™ portfolio of assays and the clinical labs team for North America. Vonda is currently focused on supporting the global regions with our PlGF tests, that is, placental growth factor, and toxicology assays, as well as expanding the Triage toxicology and women's health testing portfolio. She also serves as global leadership co-chair for the QuidelOrtho Women's Leadership Network.

This episode recorded live at the Becker's Hospital Review 15th Annual Meeting features Marschall Runge, Dean, University of Michigan Medical School; Executive Vice President, Medical Affairs, University of Michigan; and CEO of Michigan Medicine. Dr. Runge shares insights on leading a complex academic health system, driving integration across hospitals, managing financial headwinds, and embracing AI and digital innovation to shape the future of care.

Marc Cox talks with Dr. William Soliman, Founder and CEO of the Accreditation Council for Medical Affairs, about the administration's historic push to lower drug prices—particularly for Medicare patients. Dr. Soliman breaks down why Americans pay up to 15 times more for medications than those in other countries, the role of pharmacy benefit managers in inflating costs, and how pharmaceutical companies navigate R&D timelines and profit windows. They also explore the market dynamics behind global drug pricing and challenges facing privately insured patients in accessing life-saving medications.

In Medical Communications, survival isn't about using AI; it's about mastering it. In this episode of Transforming Medical Communications, Wesley Portegies is joined by AI strategist Subir Roy to discuss why mastering AI is no longer optional for leaders in Medical Affairs; it's a competitive necessity. Learn how to eliminate inefficient processes, spot AI "hallucinations," and leverage human expertise to make smarter, faster decisions. AI can save you hours every day, but only if you know how to use it. The future belongs to those who harness AI as a strategic asset; those who don't risk being left behind. This is your wake-up call: Master AI or risk becoming irrelevant.

Hosted by Drew Beck, Head of Strategy, Growth and Innovation for Syneos Health Learning Solutions, this limited series dives into the breakthrough trends redefining health in 2025 and beyond. From bold moves in R&D and medical affairs to next-gen trial design, product launch strategies and the future of healthcare communications, each episode connects you with the minds driving real change. Big ideas. Real-world impact. In this episode, Drew dives into launch excellence in 2025 with Syneos Health experts Larry Dollar, VP of Medical Affairs, and Michael Sarshad, Managing Director, Consulting. Together, they unpack how strategic spending, agile planning and early investment in medical resources are driving launch success. They explore the rise of new medical affairs roles using the transformative impact of AI on clinical trials, and the evolving needs of field teams. The discussion also highlights how innovations like machine learning–driven physician segmentation are helping companies identify new clinical trial sites faster and more precisely. Whether you're with an emerging biotech or a large pharma company, you'll get key insights on collaboration, creativity and why the year leading up to launch is more critical than ever. The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at insightshub.health. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

In this month's episode of the HAE Speaks Podcast, please join Raffi Tachdjian, MD, MPH, Associate Clinical Professor, David Geffen School of Medicine at UCLA, and Kenny Robinson, MD, Head of Medical Affairs, North America at Pharvaris, for a discussion about the full spectrum of a bradykinin-mediated angioedema attack. This podcast episode highlights the experience of the physician and those living with bradykinin-mediated angioedema, explores the nuances of attack progression and resolution, and shares strategies to inform clinical assessment and improve outcomes for individuals with HAE.We would like to thank Pharvaris for sponsoring this episode of the HAE Speaks Podcast.

Sometimes the signs of heart trouble in women don't look like what we expect—they show up as hot flashes, brain fog, or even a racing heart. When I sat down with Dr. Jayne Morgan, an incredible Cardiologist and Women's Health Advocate, we talked about how these often-overlooked symptoms during menopause can actually be clues about what's going on with your heart. We're so used to brushing things off as “just hormones,” but Dr. Jayne explains why now is the time to tune in and take them seriously. Dr. Jayne —who's not only a top Cardiologist but also Vice President of Medical Affairs at Hello Heart—is passionate about making sure women get the full picture when it comes to heart health. She breaks down how estrogen protects your heart, what happens when those levels drop, and why menopause can be a turning point for understanding your risk. We also talked about what real, thorough heart testing should include (because yes, there's more to it than just cholesterol). Her approach is practical, empowering, and honestly—something every woman deserves to hear. Women need to feel empowered, not dismissed, when they bring up symptoms—and that starts with education. We're talking about prevention, clarity, and how to stop second-guessing what your body's trying to tell you. And in line with this we'd like to empower our women, mothers especially, we'll be having a  Mother's Day Sale from May 7-11 ‘25 where we'll get you up to 25% off with bundles of your favorite products. Check out https://dranna.com for more information.   Key Timestamps: [00:00:00] Introduction. [00:05:38] Estrogen's role in heart disease. [00:10:53] What entails an adequate cardiac workup? [00:12:28] Prevention of heart disease. [00:15:47] Aggressive management of risk factors. [00:19:25] Statin therapy, hormonal management, lowering cholesterol. [00:23:57] Pregnancy as a stress test. [00:29:00] The connection of diabetes and cardiovascular disease risk. [00:30:57] The relation of heart disease to early dementia and early stroke. [00:32:22] Who can have hormone replacement therapy?   Memorable Quotes: "All of these symptoms in perimenopause and menopause are actually biomarkers for heart disease, biomarkers for stroke." [00:06:47] – Dr. Jayne Morgan "Heart disease is the number one killer of women, and you, as a patient or a member of the public, do not have the ability to discern whether your palpitations that you're having at home are related to your perimenopause or related to a real heart issue that could pose an impending heart attack." [00:09:08] – Dr. Jayne Morgan   Links Mentioned: Mother's Day Sale from May 7- 11 ‘25 – https://dranna.com   Connect with Dr. Jayne Morgan: Linktree: https://linktr.ee/DrJayneMorgan Instagram: https://www.instagram.com/drjaynemorgan/ YouTube: https://www.youtube.com/@DrJayneMorgan LinkedIn: https://www.linkedin.com/in/jaynemorgan/   Connect with Dr. Anna Cabeca: Website: https://drannacabeca.com/pages/show Instagram: https://www.instagram.com/thegirlfrienddoctor/ YouTube: https://www.youtube.com/@thegirlfrienddoctor TikTok: https://www.tiktok.com/@drannacabeca   Produced by Evolved Podcasting: https://www.evolvedpodcasting.com

Listen as coinvestigator and rheumatologist Dr. Andrea Rubbert-Roth reviews this Phase 3 trial of a JAKi in patients with giant cell arteritis. Dr. Rubbert-Roth discusses the latest results, including efficacy and safety outcomes.

Welcome to another episode of Beyond the Thesis With Papa PhD—a podcast where we dive deep into what happens after the PhD and how you can leap from academia into a diverse universe of fulfilling careers. This week, host David Mendes sits down in-person with Rayana Luna, a seasoned expert in medical affairs with over a decade of experience spanning multiple leadership roles, industry transitions, and a consulting business: Your MSL Coach. In this in-depth conversation, Rayana shares her journey from doing a PhD and feeling locked into the traditional academic path, to discovering the world of medical science liaison (MSL) roles and climbing the career ladder in medical affairs. She opens up about the realities of breaking into the industry, the variety of entry-level roles available (including MSLs, medical writers, and more), and sheds light on salary expectations—spoiler: they're generally higher than postdoc salaries! Rayana also addresses common hurdles PhDs face when shifting careers, like learning to “sell” yourself beyond an academic CV, mastering LinkedIn, and networking with authenticity. Packed with actionable advice, inspiring stories, and a deep dive into what medical affairs teams actually do in big pharma, this episode is a must-listen for anyone considering taking their research skills Beyond the Thesis. Rayana Luna's career journey is a testament to growth and adaptability within the medical affairs field. Starting out, Rayana observed that roles like medical science liaison (MSL), medical advisor, and medical writer not only offered higher starting salaries than traditional postdoctoral positions, but also provided abundant opportunities for advancement. Over the span of ten years, Rayana changed positions six times, quickly climbing the career ladder by focusing on collaborative environments and personal fulfillment over prestigious titles or starting pay. Her story encourages valuing meaningful work and positive teamwork, reinforcing that career progression comes naturally when you do what you love and build strong professional relationships. What we covered in the interview:  Career Progression is Fast & Rewarding: Entry-level roles like medical affairs fellow or MSL may seem humble, but with consistent performance and strategic networking, career (and salary) growth can be rapid. “Don't get hung up on initial titles; focus on enjoying your work and collaborating with great people.”  Networking & Self-Advocacy are Essential: Start intentional networking early (don't wait until you need a job!) and tailor your LinkedIn to what you WANT to do—not just what you've done. Your visibility and authentic connections can open unexpected doors.  Your Advanced Degree Matters: Finishing your PhD is increasingly required for most roles in medical affairs and opens many more doors for your industry trajectory. Don't give up in the final stretch—your perseverance will pay off.  If you're prepping for your next step, focus on crafting a standout LinkedIn profile, invest in building genuine connections, and keep an open (and growth-oriented) mindset. There's a whole world of opportunity beyond the bench!   See the resources section below for her links! This episode's resources: Instagram: @your.msl.coach LinkedIn: Your MSL Coach Thank you, Rayana Luna! If you enjoyed this conversation with Rayana, let her know by clicking the link below and leaving her a message on Linkedin: Send Rayana Luna a thank you message on Linkedin! Click here to share your key take-away from this interview with David! Leave a review on Podchaser ! Support the show !   You might also like the following episodes: Sarah McLusky – Research Adjacent Podcast Collab Papa PhD Gold – Sue Ashford – Four Practices You Must Learn From Gig Workers Papa PhD Gold – Elodie Chabrol –The Hidden Benefits of Science Communication Alexandra Howson – A Career in Continuing Medical Education

Digital engagement in Medical Affairs is broken, and you know it. You've got channels that don't connect, metrics that don't matter, and “innovations” that die in MLR review. It's not your fault. But it is fixable. In this episode of Transforming Medical Communications, Wesley Portegies is joined by digital strategist Alessandra Richardson to unpack the broken realities of digital engagement and how to build tools that actually work. This isn't about adding more platforms. It's about connecting the right ones, co-creating with the people you serve, and aligning teams from field to MLR to create measurable, meaningful impact. If you're tired of spinning in digital circles, this is your reset.

Dr. Isabelle Raymond is an author and scientific leader in pharmaceutical and biotech industries, more recently working in beauty and wellness. She has authored over 80 publications and textbook chapters and books in several therapeutic fields including aesthetic medicine, dermatology, sleep disorders and pain management. She is currently the Head of Clinical and Medical Affairs at Nutrafol. She joins the show to discuss the hair growth cycle, how our hair changes throughout different stages of life, and why clinical research is essential when it comes to nutraceuticals.This episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct, or indirect financial interest in products, or services referred to in this episode.Visit Nutrafol.com and enter code BLONDE for $10 off your first month and free shipping. Visit masachips.com and use promo code BLONDE to get 20% off your first order.Visit justthrivehealth.com and save 20% with promo code WellVisit oneskin.co/well and use code WELL for 15% off your first order.Produced by Dear MediaSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Physician shortages in the U.S. are affecting health systems and organizations nationwide and are predicted to have long-lasting effects on public health. According to the Association of American Medical Colleges, the U.S. is facing a shortage of up to 124,000 physicians by 2034, including 48,000 primary care physicians. Dr. Marschall Runge, Executive Vice President for Medical Affairs at the University of Michigan and CEO of Michigan Medicine joined us to discuss the shortages and how technological advances, policy changes, and emerging business models are fundamentally transforming American healthcare.Listen to WBZ NewsRadio on the NEW iHeart Radio app and be sure to set WBZ NewsRadio as your #1 preset!

In the face of vaccine skepticism and misinformation, here's how two passionate public health leaders, Kelly Moore, President and CEO of Immunize.org, and Piyali Mukherjee, Vice President of Medical Affairs at Moderna Asia Pacific, are getting the truth out about the power of immunization and prevention. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002404?ecd=bdc_podcast_libsyn_mscpedu

We kicked off the program with four news stories and different guests on the stories we think you need to know about!Dr. Marschall Runge - executive vice president for Medical Affairs at the University of Michigan, dean of the Medical School, and CEO of Michigan Medicine discussed how technological advances, policy changes, and emerging business models are fundamentally transforming American healthcare.MONSTER JAM® returns to Gillette Stadium on Saturday, April 12th! Dan spoke with driver Colt Stephens.Lowell, MA's multi-day celebration of music and art, The Town and The City Festival - APRIL 24-26 in Downtown Lowell. Chris Porter - Festival founder checked in with Dan.Skipping meals may increase risk of heart attack… Dr. Fahmi Farah – Cardiologist and director of Bentley Heart in Fort Worth, Texas joined Dan Rea.Listen to WBZ NewsRadio on the NEW iHeart Radio app and be sure to set WBZ NewsRadio as your #1 preset!

Being a pharmacist is exciting–as long as you're willing to try new things. These are wise words from my returning guest on today's podcast, who has been paving the way for integrative pharmacy. Dr. Swathi Varanasi is an award-winning pharmacist passionate about the intersection of personalized medicine, patient outcomes, and innovation. With experience spanning patient care, biotech, research, academia, and consumer product goods, Dr. Swathi has paved the way for healthcare professionals to pursue non-traditional career paths through creating postdoctoral training programs, industry internships, and online educational programs. She co-founded and serves as Chief Scientific Officer of the Life Sciences Division at Element Apothec, and serves as a Principal Investigator at contract research organization, Citruslabs. Dr. Swathi received her Doctor of Pharmacy (PharmD) at the Medical University of South Carolina and Bachelor of Arts (BA) at Carleton College. She was the first-ever pharmacist in the United States with formal residency training to specialize in integrative medicine and preventative health. She also completed a postdoctoral fellowship in Medical Affairs in biotech and has training in nutrition from Cornell University. Dr. Swathi has served as faculty and guest lectures at colleges and universities across the country. She is an advisor and consultant for a number of for-profit and nonprofit organizations aiming to make the world a healthier place for us to live–and thrive. She has been published in peer-reviewed academic journals and featured in Yahoo, mindbodygreen, Well+Good, Entrepreneur, Forbes Health, and more. In 2023, Dr. Swathi was voted one of the 50 Most Influential Leaders in Pharmacy. Connect with Dr. Swathi via: Email: swathimvaranasi@gmail.com FB: Doctor Swathi IG: @doctorswathi Linked In:Dr. Swathi Varanasi Check out our earlier episode here: https://www.marinabuksov.com/s03e03-paving-the-unconventional-path-with-integrative-pharmacist-dr-swathi-varanasi/ Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

James Matera, DO, FACOI, ACPE, Senior Vice President of Medical Affairs and Chief Medical Officer at CentraState Medical Center, discusses the importance of evidence-based medicine and adhering to guidelines to enhance care quality. He also highlights how the organization is addressing community needs and emphasizes the role of monitoring key performance metrics to drive improvement.

In this episode, Dr. Denise Jamieson, the Vice President for Medical Affairs and Dean of the Carver College of Medicine at the University of Iowa, shares her vision and priorities for improving healthcare in Iowa. She focuses on serving the state's 3.2 million residents through clinical care, education, and research at UI Health Care. Dr. Jamieson discusses her goal of building an integrated, efficient health system that ensures the right care is delivered at the right time and place, while also tackling challenges related to access and workforce shortages. A key topic is her emphasis on the importance of clear communication, particularly during public health crises, and the need to rebuild trust in science and public health efforts. Drawing from her unique experience at the intersection of clinical medicine and public health, Dr. Jamieson outlines how this perspective informs her leadership approach. She concludes by expressing her enthusiasm for the future of academic medicine and the potential for the next generation to drive impactful change in Iowa and beyond. A transcript of this episode is available at https://www.public-health.uiowa.edu/news-items/plugged-in-to-public-health-a-conversation-with-denise-jamieson/ Have a question for our podcast crew or an idea for an episode? You can email them at CPH-GradAmbassador@uiowa.edu You can also support Plugged in to Public Health by sharing this episode and others with your friends, colleagues, and social networks. #publichealth

Some changes coming to Tandem's Control IQ software… which will now be called Control IQ Plus. What have they added? I'm talking with Dr. Laurel Messer, senior director of Medical Affairs at Tandem to answer your questions about this software update, type 2 indication, whatever happened to Tandem's new infusion sets and reusable patch pump, and lots more. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Important Safety Information: RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: tandemdiabetes.com/safetyinfo.    Join us at an upcoming Moms' Night Out event! Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

In this episode of The Backstory, host Anne Hancock Toomey interviews Dr. David Miller, President of University of Michigan Health and incoming Executive Vice President for Medical Affairs of University of Michigan and CEO of Michigan Medicine . Dr. Miller shares insights from his career as a urologic cancer surgeon and member of the leadership team at a large academic health system. He discusses his Michigan roots, the influence of his parents, and and the surprising role the CEO of Dow had on his journey from practicing medicine to taking on significant administrative roles. The conversation delves into his leadership philosophy, which emphasizes honesty, humility, visibility and enthusiasm. Dr. Miller also talks about balancing his clinical practice with his executive responsibilities. As a physician and executive, he is well-placed to talk about the importance of earning and maintaining trust from colleagues, team members and the public. 2:05 Early Life and Influences 4:46 First Job and Lessons Learned 8:25 College and Medical School Journey 9:31 Choosing Urology and Career Path 13:50 Transition to Administration 17:30 Balancing Clinical Practice and Leadership 19:43 Upcoming Role as CEO 22:36 Addressing Trust in Healthcare 27:19 Family and Personal Life 30:04 Leadership Insights and Advice 34:43 Lightning Round and Closing Remarks Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Skin Anarchy, we dive into the science of hair health with Dr. Isabelle Raymond, Senior VP of Clinical and Medical Affairs at Nutrafol. With a PhD in biomedical science and expertise in dermatology and pharmaceutical research, Dr. Raymond breaks down the science-backed approach Nutrafol takes to hair growth, scalp health, and supplementation.For years, the supplement industry has lacked regulation, leaving many consumers skeptical. Dr. Raymond shares how Nutrafol is changing the game with rigorous clinical trials, using macro photography, hair count analysis, and physician evaluations to ensure real, measurable results. Unlike products that focus solely on biotin, Nutrafol's formulas target stress, hormonal imbalances, gut health, and oxidative stress, recognizing that hair wellness starts from within.Women's hair health is often overlooked, especially when it comes to postpartum recovery and menopause. Dr. Raymond shares how Nutrafol's tailored formulations provide support through hormonal shifts and why addressing inflammation and nutrient absorption is key to maintaining strong, healthy hair at any age.Looking ahead, Nutrafol is at the forefront of new research into autoimmune-related hair loss, gut health, and inflammation, proving that supplements can be both safe and effective when backed by science.If you're curious about how to improve hair growth and scalp health with clinically proven solutions, tune in to this insightful episode of Skin Anarchy!To learn more about Nutrafol, visit their website and social media. Don't forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform. Reach out to us through email with any questions.Shop all our episodes and products mentioned through our ShopMy Shelf!*Sponsored by Nutrafol Hosted on Acast. See acast.com/privacy for more information.